GGrantIndex
← Search

A PHASE II RANDOMIZED, CROSS-OVER STUDY TO COMPARE THE STEADY STATE PHARMACOK

$7,202M01FY2007RRNIH

Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center, Torrance CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →